1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid methyl ester, 98%, 5g

2-N-phenylpyridine-2,4-diamine, 97%, 5g

Chloro[1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene]silver, 97%, 1g

(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate, 95%, 50mg

2,3,4,6-Tetra-O-benzoyl-D-mannopyranose>93.0%(HPLC)1g

Isobutyl 4-hydroxybenzoate, 99.0%, 1kg

2-(1H-imidazol-1-yl)acetohydrazide dihydrochloride, 95.0%, 1g

Agarose Low Melt, 5 g

bScope BS.1152-EPLPH for phase contrast. Biocular with HWF 10x/20 mm eyepieces and Quadruple revolver E-plan Phase 10/20/S40 S100x

2-(Hydroxymethyl)anthracene-9,10-dione, 250mg

Methyl 3-hydroxy-2-nitrobenzoate, 95.0%, 10g

4-Ethyl-4-methylpiperidine-2,6-dione, 95.0%, 1g

6-(Chloromethyl)nicotinic acid, 98%, 250mg